Multiple Stakeholders Send Letter to Secretary Sebelius Urging One-Year Transition Period for AMP- Based FULs (Including a primer on the history and acronyms) By: Chris Cobourn | On: April 15, 2014 | In: CIS Compliance Blog | General | Government Programs In an April 9th letter to CMS, multiple stakeholders sent a joint letter to […]
TRxADE.com announces the release of the RxGuru. RxGuru is a downloadable desktop application that simplifies the complex process of comparing pharmaceutical pricing and source availability for Independent Pharmacy. RxGuru is a must-have tool for today’s community pharmacist. This revolutionary no-cost tool provides, at a glance, all of the following data features: * Pricing and availability […]
Sun Pharma hopes to turn fortunes of Ranbaxy around with $3.2B buyout The all-stock deal would make Daiichi Sankyo Sun’s largest shareholder with a 9% stake April 7, 2014 | By Eric Palmer Sun Pharmaceutical Industries has been shopping for deals that would give it more exposure to the U.S. market, and now it has pulled […]
Pfizer stock trades halted over drug patent ruling Original Post: bigstory.ap.org – By LINDA A. JOHNSON — Mar. 12, 2014 5:36 PM EDT TRENTON, N.J. (AP) — A federal court on Wednesday invalidated the key patent for one of Pfizer’s most lucrative medicines, potentially opening the door for cheaper generic versions 18 months sooner than […]
Trxade Health, Inc. (NASDAQ: MEDS)